Investment Rating - The report assigns an "Outperform" rating to the company, indicating an expected relative performance above the market benchmark over the next 12-18 months [4][14]. Core Insights - The company has significantly reduced losses, with promising potential in satellite communication and other innovative businesses. Despite revenue pressure in the first three quarters of 2025, the net loss attributable to shareholders has narrowed year-on-year, and Q3 revenue showed growth, reflecting improved operational quality [4][14]. - The company is strategically investing in high-potential areas such as satellite internet and 5G-A technology, which are expected to drive new growth despite short-term challenges in traditional business segments [4][14]. Financial Summary - Total revenue for the first three quarters of 2025 was 3.76 billion RMB, a decrease of 9.25% year-on-year. However, Q3 revenue was 1.23 billion RMB, representing a growth of 6.23% year-on-year, indicating marginal improvement [4][14]. - The net loss attributable to shareholders was 165 million RMB, a reduction of approximately 4.8 million RMB year-on-year. The net loss after non-recurring items was 206 million RMB [4][14]. - The company has shown strong cost control, with sales and R&D expenses decreasing by 8.56% and 4.03% year-on-year, respectively [4][14]. Business Segments - In the main equipment business, the company increased its bid amounts and market share despite reduced operator investment [4][14]. - The antenna and indoor distribution business maintained a leading position in the industry, with significant market share in antenna centralized procurement and indoor equipment [4][14]. - The industry applications segment emerged as a growth highlight, focusing on energy and transportation, with over 80% revenue growth projected for 2024 [4][14]. Strategic Initiatives - The company is advancing its strategic investments in integrated air-space-ground systems, aiming to build new growth areas [4][14]. - It is fully engaged in the evolution of 5G-A technology and has pioneered a 64T128R integrated solution, positioning itself to lead in low-altitude economy scenarios [4][14]. - The company possesses end-to-end capabilities in satellite internet, from baseband to core network, and is deeply involved in GW construction, expected to benefit from industry growth [4][14]. Management and Reforms - The company is implementing management reforms to enhance internal motivation and operational quality, including performance-based public recruitment by the end of 2024 [4][14].

Investment Rating - The report assigns an "Outperform" rating to the company, with a target price of 362.59 RMB [4][14][15]. Core Insights - The company is experiencing continuous sales growth of Zebutinib, with significant advancements in its pipeline for solid tumors and hematological cancers, indicating a strong potential for sustained revenue growth [1][4][17]. - The company has raised its full-year guidance, projecting total revenue between 5.1 to 5.3 billion USD for the year, reflecting a positive shift in operational profitability [15][16]. - The report highlights the promising clinical progress of the company's CDK4 inhibitor and other solid tumor pipelines, which are expected to contribute to future revenue streams [16][17]. Financial Summary - Projected revenues for 2025-2027 are 37.26 billion, 45.31 billion, and 51.15 billion RMB, with year-on-year growth rates of 36.9%, 21.6%, and 12.9% respectively [3][4]. - Net profit attributable to shareholders is expected to be 2.05 billion, 4.26 billion, and 5.30 billion RMB for the years 2025-2027 [4][14]. - The company reported a total revenue of 1.41 billion USD in Q3 2025, with a quarter-on-quarter growth of 7.37% [15].

Investment Rating - The report maintains an "Outperform" rating for the company, projecting a target price of RMB 60.13 based on a 2025 PE of 40x [5][9]. Core Insights - The operator business is under pressure due to delivery pace and downstream demand, but the computing power business is accelerating its growth [1]. - Revenue for the first three quarters of 2025 reached RMB 100.52 billion, a year-on-year increase of 11.63%, while net profit attributable to shareholders was RMB 5.32 billion, down 32.69% year-on-year [5][9]. - The computing power business saw significant growth, with government and enterprise business up 130% year-on-year and computing power business scale reaching approximately RMB 25 billion, up 180% year-on-year [5][9]. Financial Summary - Total revenue projections for 2025-2027 are RMB 141.34 billion, RMB 155.97 billion, and RMB 173.35 billion, respectively [5][9]. - Net profit attributable to shareholders is projected at RMB 7.19 billion, RMB 8.32 billion, and RMB 9.92 billion for the same period [5][9]. - The gross profit margin for Q3 2025 was 30.55%, down 9.88 percentage points year-on-year, while the net profit margin was 5.29%, down 3.49 percentage points year-on-year [5][9]. Business Performance - The operator business's revenue is under pressure due to a decline in capital expenditure and changes in delivery pace, while the government and enterprise/server business has shown accelerated growth [5][9]. - The company is focusing on enhancing its chip business, which is expected to become a new profit engine, leveraging self-developed chips and AI servers [5][9]. - The company won a major breakthrough award at the 2025 China Computing Power Conference for its intelligent computing super node system [5][9].

股票研究 /[Table_Date] 2025.11.11 2025-11-12 降幅收窄供给分化，龙头变革预期改善 酒店行业更新报告 本报告导读： 经营数据降幅持续改善，供给已经出现结构性变化，龙头各有改善，行业有望迎来 明显估值修复。 投资要点： 股 票 研 究 行 业 专 题 研 究 证 券 研 究 报 告 请务必阅读正文之后的免责条款部分 [table_Authors] [Table_Summary] 投资观点：预计酒店将受益行业经营数据降幅收窄、公司个股变革 预期提振，以及股本结构优化和板块资金偏好催化，估值明显修复。 重点标的：华住集团、锦江酒店、首旅酒店。相关标的：亚朵。 景气度环比持续改善，但持续性仍有争议。①自 2025 年 7 月以来， 酒店行业及龙头 RevPAR 降幅持续收窄呈现出明显环比改善趋势。 十一后，环比改善趋势延续。②量价维度拆分，价格表现好于 OCC。 2025 年酒店主动调整运营策略：追求 OCC 和 ADR 均衡，而非高 OCC， 以获取最大化利润率。③酒店能够提价成功，也和行业特征有关： 供给强区域特征，其他区域供给并不对本区构成影响。酒店价格是 区域酒店选定标杆酒店 ...

Investment Rating - The report suggests a positive outlook for the baijiu industry, indicating a potential market style shift benefiting the sector as CPI data improves [3][6][9] Core Insights - October CPI data shows a year-on-year increase of 0.2%, the highest since February 2025, indicating a recovery in domestic demand, particularly in the service sector [7][9] - The baijiu industry is expected to see a bottoming out of sales and inventory adjustments within the next 2-3 quarters, with Q3 reports showing significant revenue declines [8][9] - Valuations for baijiu companies are currently low, with a dividend yield of 3.74%, making them attractive compared to the broader market [9] Summary by Sections CPI and Market Sentiment - The October CPI data reflects a positive trend, with core CPI rising by 1.20% year-on-year, signaling improved market confidence and domestic demand expectations [7][9] Industry Performance - The baijiu industry is experiencing a phase of adjustment, with Q3 revenues down 18% year-on-year and net profits down 22%, indicating a need for several quarters for full recovery [8][9] Valuation and Investment Opportunities - Current valuations for baijiu stocks are at historically low levels, with the sector offering a higher dividend yield compared to the broader market indices, suggesting potential for capital appreciation [9]

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - The AI server market is experiencing a power supply revolution with the adoption of Battery Backup Units (BBUs) equipped with supercapacitors, driven by increasing demand from AI applications [1][13] - The ultra-slim smartphone market is polarized, with traditional bar-type models facing declining sales while foldable models are gaining traction, particularly from Chinese brands like OPPO [2][15] - Qualcomm is expected to maintain a dominant position in the Galaxy S26 series, supplying approximately 75% of the processors, indicating strong market confidence [3][16][17] - China's flexible export controls and exemptions are strategically aimed at managing supply chain disruptions while protecting its interests, reflecting a dual approach in international trade dynamics [4][18][19] Summary by Sections AI Server Power Supply - The BBU with supercapacitors is becoming a key component in AI servers, with demand increasing due to the AI server wave [1][13] - Major international players, including companies from the U.S., Japan, and South Korea, are actively developing supercapacitor products [2][14] Ultra-Slim Smartphone Market - The market is showing a split trend, with bar-type models like Apple's iPhone Air struggling, while foldable models are gaining popularity [2][15] Semiconductor Market - Qualcomm's Snapdragon is projected to dominate the Galaxy S26 series, maintaining a significant market share [3][16][17] Trade and Export Controls - China's Ministry of Commerce is using export controls and exemptions to navigate international trade challenges, aiming to protect domestic interests while engaging with global partners [4][18][19]

wo[Table_Title] Research Report 12 Nov 2025 事件 中国电子 China (Overseas) Technology 全球科技业绩快报：Coreweave 25Q3 CoreWeave 3Q25 — Strong Beat, Growing Backlog, and Prudent Financing Amid Shell Delays 姚书桥 Barney Yao 吕小潼 Xiaotong Lyu barney.sq.yao@htisec.com xt.lyu@htisec.com [Table_yemei1] Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) Coreweave 25Q3 业绩表现：2025 年 11 月 10 日盘后公布第三季度业绩，期内实现收入 14.0 亿美元，同比增长 134%，高出市场预期；调整后每股收益为-0.22 美元，显著优于市场预期。盈利能力方面，调整后经营利润为 2.17 亿美元，对应利润率 16%；调整后 EBITDA 达 8. ...

Investment Rating - The report assigns an "Outperform" rating to multiple companies including Nike, Midea Group, JD Group, Haier Smart Home, Gree Electric, Anta Sports, China Duty Free, and others [1]. Core Insights - The report highlights that domestic and overseas consumer subsectors are not showing synchronized movements, with internal factors driving stock performance [4][10]. - The performance of various sectors is analyzed, indicating that the U.S. hotel sector has outperformed others, while luxury goods and overseas cosmetics have seen significant declines [10][13]. Sector Performance Summary - **U.S. Hotels**: The sector saw a weekly increase of 7.9%, driven by strong performance from Marriott and Hilton, with Marriott's RevPAR growth meeting market expectations [5][13]. - **Pet Sector**: Increased by 1.1%, with leading brands showing significant growth in GMV despite overall sales being weak [5][13]. - **Gambling Sector**: Rose by 0.7%, with Macau's GGR exceeding expectations, indicating strong future performance [5][13]. - **Retail Sector**: Experienced a slight decline of 0.3%, with China Duty Free benefiting from new tax policies [7][13]. - **Snack Sector**: Fell by 1.9%, with competitive pressures affecting performance [7][13]. - **Gold and Jewelry Sector**: Decreased by 2.5% due to tax reforms impacting profitability [7][13]. - **Overseas Sportswear**: Dropped by 2.8%, facing tariff pressures and concerns over U.S. consumer spending [7][13]. - **Luxury Goods**: Declined by 3.0%, with concerns over upcoming earnings reports affecting stock prices [7][13]. - **Domestic Cosmetics**: Fell by 3.4%, with overall performance weaker than international brands [7][13]. - **Overseas Cosmetics**: Experienced a significant drop of 11.6%, primarily due to ELF Beauty's disappointing earnings [7][13]. Valuation Analysis - Most sectors are valued below their average over the past five years, with specific PE ratios indicating potential undervaluation [8][14]. - **Overseas Sportswear**: Expected PE of 28.6, 54% of the past five-year average [14]. - **Domestic Sportswear**: Expected PE of 14.1, 74% of the past five-year average [14]. - **Gold and Jewelry**: Expected PE of 22.1, 42% of the past five-year average [14]. - **Luxury Goods**: Expected PE of 25.6, 46% of the past five-year average [14]. - **Gambling**: Expected PE of 29.1, 47% of the past five-year average [14]. - **Overseas Cosmetics**: Expected PE of 35.5, 53% of the past five-year average [14]. - **Domestic Cosmetics**: Expected PE of 27.9, 52% of the past five-year average [14]. - **Pet Sector**: Expected PE of 40.3, 55% of the past five-year average [14]. - **Snack Sector**: Expected PE of 26.8, 65% of the past five-year average [14]. - **Retail Sector**: Expected PE of 28.6, 53% of the past five-year average [14]. - **U.S. Hotels**: Expected PE of 31.4, 19% of the past five-year average [14]. - **Credit Card Sector**: Expected PE of 28.9, 55% of the past five-year average [14].

Investment Rating - The investment rating for the company has been adjusted to "Neutral" [4][9]. Core Insights - The report highlights that the company's core product line, the Pian Zai Huang series, is facing pressure on revenue growth and gross margin due to factors such as a challenging consumption environment and high costs of raw materials [1][4]. - The company achieved a revenue of RMB 7.44 billion in the first three quarters of 2025, representing a year-on-year decline of 11.93%, with a net profit attributable to shareholders of RMB 2.13 billion, down 20.74% year-on-year [4][9]. - The report anticipates potential recovery in consumption and a decrease in raw material costs, which could present future opportunities for the company [1]. Financial Summary - The financial summary indicates projected total revenues for 2025-2027 of RMB 9.65 billion, RMB 9.96 billion, and RMB 10.63 billion, with corresponding net profits of RMB 2.39 billion, RMB 2.62 billion, and RMB 2.94 billion [3][4]. - The earnings per share (EPS) are forecasted to be RMB 3.96, RMB 4.35, and RMB 4.87 for the years 2025, 2026, and 2027 respectively [4][9]. - The report notes a significant decline in the revenue from liver disease medications, which totaled RMB 3.88 billion in the first three quarters of 2025, down 9.4% year-on-year [4][9]. Quarterly Performance - In Q3 2025, the company reported a revenue of RMB 2.06 billion, a decrease of 26.28% year-on-year, and a net profit of RMB 687 million, down 28.82% year-on-year [4][9]. - The gross profit margin (GPM) for liver disease medications was 61.1%, reflecting a year-on-year decrease of 9.7 percentage points, but showing signs of stabilization [4][9]. Business Segment Performance - The cardiovascular medication segment saw a revenue drop of 65.2% year-on-year, while the cosmetics segment reported a revenue decline of 23.8% [4][9]. - The pharmaceutical commerce segment generated RMB 2.89 billion in revenue, down 8.5% year-on-year, with a GPM of 8.6% [4][9].

Market Performance - The global market experienced a general decline, with MSCI Global down by 1.4%, MSCI Developed Markets down by 1.5%, and MSCI Emerging Markets down by 1.0%. However, the Chinese stock market rose against this trend, with the Hang Seng Index increasing by 1.3% [7][11][12]. - In the bond market, the UK 10Y government bond yield saw a significant increase of 6.6 basis points, while the US yield remained unchanged [7][12]. Trading Sentiment - The short-selling ratio in the Hong Kong stock market reached its highest level since April, at 16.9%, indicating a low investor sentiment historically [21][24]. - Trading volumes showed mixed results, with the Shanghai Composite Index's trading volume decreasing to 305.2 billion shares, while the Hang Seng Index's trading volume increased to 150 billion shares [21][35]. Earnings Expectations - Earnings expectations for the Hong Kong market were revised upward, with the Hang Seng Index's 2025 EPS forecast increased from 2065 to 2073. The financial sector saw the most significant upward revision [64][65]. - In the US, the S&P 500's 2025 EPS forecast was adjusted from 270 to 271, with the industrial sector experiencing the largest increase [64][65]. - European markets also saw upward revisions, with the Eurozone STOXX50's 2025 EPS forecast rising from 333 to 334, particularly in the energy sector [64][65]. Economic Outlook - The economic sentiment in Europe improved, with the economic surprise index showing a significant increase, supported by strong demand in the industrial sector [7][64]. - In contrast, the US economic surprise index declined due to uncertainties surrounding the Federal Reserve's interest rate decisions and the government shutdown [7][64]. Fund Flows - There was a notable inflow of funds into the Hong Kong stock market, with a total of 116 billion HKD entering the market recently, primarily through the Stock Connect program [59][63]. - The Federal Reserve's interest rate outlook for December has become more divided, with market expectations indicating a potential rate cut of 0.67 times by the end of the year [51][54].